| | Cancer | Skin Cancer
Purple Skin Lesions in Terminal Cancer: Evaluation and Differential Diagnosis
New purple skin lesions in a patient with terminal cancer require prompt clinical assessment. While concerning, they are not universally malignant.
Possible Causes
- Metastatic deposits: Cutaneous metastases (breast, lung, melanoma, renal) can appear violaceous
- Kaposi sarcoma: HHV-8 associated; violaceous patches/nodules; increased in immunosuppression
- Vasculitis/leukocytoclastic vasculitis: Palpable purpura from immune complex deposition
- Coagulopathy/bleeding: Thrombocytopenia, DIC, anticoagulants → ecchymoses, petechiae
- Drug reactions: Chemotherapy agents (e.g., taxanes, bleomycin) can cause pigmentation or vasculitis
- Radiation recall/dermatitis: In previously irradiated fields
- Infection: Ecthyma gangrenosum (Pseudomonas), fungal angioinvasion
- Benign: Cherry angiomas, venous lakes, trauma
Evaluation
- History, medication review, physical exam (dermoscopy)
- Biopsy if diagnosis uncertain
- CBC, coagulation, inflammatory markers
Management
Directed at underlying cause. Palliative focus: comfort, bleeding control, infection prevention, cosmetic concern. Multidisciplinary coordination (oncology, dermatology, palliative care) optimizes quality of life.
Skin Cancer - Related Articles
- Malignant Melanoma: Understanding Risk, Symptoms & Treatment
- Post-Removal Skin Cancer Treatment: What to Expect
- Understanding UV Rays & Their Impact on Skin Health
- Protect Your Skin: Understanding and Reducing Skin Cancer Risk
- Understanding Lip Skin Cancer: Types, Risks & Treatment
- Squamous Cell Skin Cancer: Symptoms, Causes & Prevention
- Melanoma Treatment Options & Early Detection
